Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2025-12-25 @ 9:32 PM
NCT ID: NCT02258451
Term: Cystitis
Organ System: Infections and infestations
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA (25.1)
Notes: None
Study: NCT02258451
Study Brief: Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 4 4 139 View
EG001 8 7 139 View